Diagnosis and Treatment > Signs and Symptoms

You are looking at 1 - 2 of 2 items for :

  • Hypogonadism x
Clear All
Carlos Tavares Bello Endocrinology Department, Hospital de Egas Moniz, Lisbon, Portugal

Search for other papers by Carlos Tavares Bello in
Google Scholar
PubMed
Close
,
Patricia Cipriano
Search for other papers by Patricia Cipriano in
Google Scholar
PubMed
Close
,
Vanessa Henriques
Search for other papers by Vanessa Henriques in
Google Scholar
PubMed
Close
,
João Sequeira Duarte
Search for other papers by João Sequeira Duarte in
Google Scholar
PubMed
Close
, and
Conceição Canas Marques
Search for other papers by Conceição Canas Marques in
Google Scholar
PubMed
Close

Summary

Granular cell tumours (GCT) are rare, slow-growing, benign neoplasms that are usually located in the head and neck. They are more frequent in the female gender and typically have an asymptomatic clinical course, being diagnosed only at autopsy. Symptomatic GCT of the neurohypophysis are exceedingly rare, being less than 70 cases described so far. The authors report on a case of a 28-year-old male that presented to the Endocrinology clinic with clinical and biochemical evidence of hypogonadism. He also reported minor headaches without any major visual symptoms. Further laboratory tests confirmed hypopituitarism (hypogonadotrophic hypogonadism, central hypothyroidism and hypocortisolism) and central nervous system imaging revealed a pituitary macroadenoma. The patient underwent transcranial pituitary adenoma resection and the pathology report described a GCT of the neurohypophysis with low mitotic index. The reported case is noteworthy for the rarity of the clinicopathological entity.

Learning points:

  • Symptomatic GCTs are rare CNS tumours whose cell of origin is not well defined that usually give rise to visual symptoms, headache and endocrine dysfunction.

  • Imaging is quite unspecific and diagnosis is difficult to establish preoperatively.

  • Surgical excision is challenging due to lesion’s high vascularity and propensity to adhere to adjacent structures.

  • The reported case is noteworthy for the rarity of the clinicopathological entity.

Open access
Anna Kopczak Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany
Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany

Search for other papers by Anna Kopczak in
Google Scholar
PubMed
Close
,
Adrian-Minh Schumacher Institute for Stroke and Dementia Research

Search for other papers by Adrian-Minh Schumacher in
Google Scholar
PubMed
Close
,
Sandra Nischwitz Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany

Search for other papers by Sandra Nischwitz in
Google Scholar
PubMed
Close
,
Tania Kümpfel Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians Universität LMU, Munich, Germany

Search for other papers by Tania Kümpfel in
Google Scholar
PubMed
Close
,
Günter K Stalla Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany

Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Close
, and
Matthias K Auer Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Munich, Germany

Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Close

Summary

The autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) syndrome is a genetic disorder caused by a mutation in the autoimmune regulator (AIRE) gene. Immune deficiency, hypoparathyroidism and Addison’s disease due to autoimmune dysfunction are the major clinical signs of APECED. We report on a 21-year-old female APECED patient with two inactivating mutations in the AIRE gene. She presented with sudden onset of periodic nausea. Adrenal insufficiency was diagnosed by means of the ACTH stimulation test. Despite initiation of hormone replacement therapy with hydrocortisone and fludrocortisone, nausea persisted and the patient developed cognitive deficits and a loss of interest which led to the diagnosis of depression. She was admitted to the psychiatric department for further diagnostic assessment. An EEG showed a focal epileptic pattern. Glutamic acid decarboxylase (GAD) antibodies, which had been negative eight years earlier, were now elevated in serum and in the cerebrospinal fluid. Oligoclonal bands were positive indicating an inflammatory process with intrathecal antibody production in the central nervous system (CNS). The periodic nausea was identified as dialeptic seizures, which clinically presented as gastrointestinal aura followed by episodes of reduced consciousness that occurred about 3–4 times per day. GAD antibody-associated limbic encephalitis (LE) was diagnosed. Besides antiepileptic therapy, an immunosuppressive treatment with corticosteroids was initiated followed by azathioprine. The presence of nausea and vomiting in endocrine patients with autoimmune disorders is indicative of adrenal insufficiency. However, our case report shows that episodic nausea may be a symptom of epileptic seizures due to GAD antibodies-associated LE in patients with APECED.

Learning points:

  • Episodic nausea cannot only be a sign of Addison’s disease, but can also be caused by epileptic seizures with gastrointestinal aura due to limbic encephalitis.

  • GAD antibodies are not only found in diabetes mellitus type 1, but they are also associated with autoimmune limbic encephalitis and can appear over time.

  • Limbic encephalitis can be another manifestation of autoimmune disease in patients with APECED/APS-1 that presents over the time course of the disease.

Open access